Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
REGN compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
REGN
Regeneron Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
REGN
Regeneron Pharmaceuticals, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes · 501d
Method
›
Moved together
REGN
with
LLY
×0.34
co-movement · LLY on REGN · 501d
r 0.34
scale to r 0.75
Shared co-movers
7
with REGN
with LLY
PFE
Pfizer Inc
r 0.43
r 0.41
AMGN
Amgen Inc
r 0.43
r 0.41
BIIB
Biogen Inc.
r 0.45
r 0.40
MRK
Merck & Co., Inc.
r 0.39
r 0.42
BMY
Bristol Myers Squibb Co
r 0.38
r 0.37
ABBV
AbbVie Inc.
r 0.35
r 0.37
REGN, solid
LLY, hatched
× = co-movement · β
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
REGN
Regeneron Pharmaceuticals, Inc.
Change
907.30
▲
+0.49%
· post 904.00
Mkt cap
$93.6B
Revenue
$5.1B
Q3 FY26
Revenue
$14.3B
FY25
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Closed
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 6 '26
REGN
Regeneron Pharmaceuticals, Inc.
vs
LLY
ELI Lilly & Co
907.30
▲
+0.49%
post 904.00
Price
1,360.90
▼
−0.28%
post 1,358.90
$93.6B
Mkt cap
$1.2T
Q3 FY26
$5.1B
Revenue
$24.4B
Q3 FY26
FY25
$14.3B
Revenue
$65.2B
FY25
Change
Change
REGN
907.30
▲
+0.49%
vs
LLY
1,360.90
▼
−0.28%
Closed
Nov 6 '26